女性2型糖尿病患者血浆Asprosin与糖脂代谢相关性分析
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金面上项目(81873648); 2016年第三军医大学苗圃人才培育项目


Plasma asprosin level are correlated with glucose and lipid metabolism in female with type 2 diabetes mellitus
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 近些年女性糖尿病患者心血管并发症发病率逐年攀升,其与肥胖密切相关;Asprosin是来源于脂 肪组织的一种蛋匂激素,具有升高血糖及增加体重的作用。本文旨在探讨血浆asprosin水平与女性2型糖尿病糖脂代 谢的关系。方法 选取50名女性2型糖尿患者和同期就诊的53名女性健康体检者为分别作为糖尿病组和对照组,对 比两组间血浆asprosin水平及糖脂代谢指标的差异;并采用Sperman相关分析及Logistic回归探讨血浆asprosin水平 与糖脂代谢、胰岛素抵抗的相关性。结果 与对照组相比,糖尿病组除有较高的空腹血糖、糖化血红蛋匂、胰岛素抵抗 指数、甘油三脂、总胆固醇、低密度脂蛋匂外,其血浆asprosin水平也明显升高(P<0.05)。相关分析提示,血浆asprosin 水平与空腹血糖、空腹胰岛素、糖化血红蛋匂、甘油三酯、总胆固醇、稳态模型评估的胰岛素抵抗指数(HOMA-IR)呈正相关(r=0.039-0.355 , P<0.05),在糖尿病组中,经校正年龄后,血浆asprosin水平与空腹血糖、糖化血红蛋匂、HO-MA-IR 呈正相关(r=0.534, P=0.000;r=0.410, P=0.003;r=0.400 P=0.004。 然而以 BMI=24 为分界线,分为 正常体重组(BMK24kg/)及超重/肥胖(BMI^24kg/m2)两个亚组,没有发现两个亚组间血浆asprosin水平有差异 (P>0.05)。经Logistic回归分析发现血浆asprosin是女性2型糖尿病的独立危险因素(P<0.05)。结论 血浆as- prosin水平与女性2型糖尿病患者糖脂代谢紊乱程度正相关,其有望成为2型糖尿病潜在预测因子。

    Abstract:

    【Abstract】 Objective In recent years, the incidence of cardiovascular complications in female diabetic patients has increased year by year, which is closely related to female obesity. Asprosin is a protein hormone derived from adipose tissue which can increase blood glucose and weight-gain. The aim of this study was to investigate the relationship between plasma asprosin level and glucose/lipid metabolism in female with type 2 diabetes mellitus. Methods 50 female patients with type 2 diabetes and 53 healthy female were selected as the diabetes group and the control group respectively. The levels of plasma asprosin and glucose/lipid metabolic indicators were compared between two groups. Sperman correlation analysis and logistic regression were conducted to illustrate the correlation between levels of plasma asprosin and glucose/ lipid metabolism profiles, as well as indicators of insulin resistance. Results Compared with the control group, the diabetic group showed higher fasting blood glucose, glycated hemoglobin, insulin resistance index, triglycerides, total cholesterol, and low-density lipoprotein, as well as they also showed significantly higher asprosin level (P<0.05). Correlation analysis indicated that the plasma asprosin level was positively correlated with fasting glucose, fasting insulin, glycated hemoglobin, triglycerides, total cholesterol, steady state model assessment of insulin resistance index(HOMA-IR) were positively correlated (r= 0. 039-0. 355, P<0.05). In the diabetic group, after adjustment for age, the plasma asprosin level was positively correlated with fasting glucose, glycosylated hemoglobin, HOMA-IR were positively correlated (r=0.534 , P=0.000 ; r=0.410 , P=0.003;r=0.400, P=0.004). However, after dividing all diabetes patients into normal body weight subgroup (BMK24kg/m2) and overweight/obesity subgroup (BMI≧24kg/m2) , no difference in plasma asprosin level was found between the two subgroups (P〉0.05). Logistic regression analysis indicated that plasma asprosin was an independent risk factor for type 2 diabetes in women (P<0.05). Conclusion The level of plasma asprosin is correlated with glucose and lipid metabolism in female with type 2 diabetes mellitus, and it may be a potential predictor of type 2 diabetes mellitus.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-10-23
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司